Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Microsoft
MSFT
|
+$834M |
| 2 |
Apple
AAPL
|
+$763M |
| 3 |
Amazon
AMZN
|
+$604M |
| 4 |
Meta Platforms (Facebook)
META
|
+$293M |
| 5 |
Johnson & Johnson
JNJ
|
+$263M |
Top Sells
| 1 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$52.4M |
| 2 |
ZAYO
Zayo Group Holdings, Inc.
ZAYO
|
+$32.8M |
| 3 |
LPT
Liberty Property Trust
LPT
|
+$29.6M |
| 4 |
MDCO
Medicines Co
MDCO
|
+$12.9M |
| 5 |
INXN
Interxion Holding N.V.
INXN
|
+$12.3M |
Sector Composition
| 1 | Technology | 23.53% |
| 2 | Healthcare | 15.94% |
| 3 | Consumer Discretionary | 11.41% |
| 4 | Communication Services | 10.49% |
| 5 | Consumer Staples | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RDUS
1776
DELISTED
Radius Health, Inc.
RDUS
| $1.11M | ﹤0.01% |
85,100
+1,300
| +2% | +$16.9K |
|
1777
Owens & Minor
OMI
$387M
| $1.1M | ﹤0.01% |
120,500
| – | – |
|
|
EBSB
1778
DELISTED
Meridian Bancorp, Inc.
EBSB
| $1.1M | ﹤0.01% |
98,300
+1,300
| +1% | +$14.6K |
|
1779
Madrigal Pharmaceuticals
MDGL
$9.46B
| $1.1M | ﹤0.01% |
16,500
+300
| +2% | +$20K |
|
1780
National Research Corp
NRC
$371M
| $1.1M | ﹤0.01% |
24,200
+400
| +2% | +$18.2K |
|
1781
York Water
YORW
$439M
| $1.1M | ﹤0.01% |
25,200
+400
| +2% | +$17.4K |
|
1782
Travere Therapeutics
TVTX
$2.03B
| $1.09M | ﹤0.01% |
75,000
+1,000
| +1% | +$14.6K |
|
1783
United Parks & Resorts
PRKS
$2.8B
| $1.09M | ﹤0.01% |
99,200
+1,400
| +1% | +$15.4K |
|
1784
Columbus McKinnon
CMCO
$432M
| $1.09M | ﹤0.01% |
43,611
+700
| +2% | +$17.5K |
|
1785
DNOW Inc
DNOW
$1.61B
| $1.09M | ﹤0.01% |
211,000
+2,700
| +1% | +$13.9K |
|
1786
Ambac
AMBC
$400M
| $1.09M | ﹤0.01% |
88,200
+1,100
| +1% | +$13.6K |
|
1787
Cerence
CRNC
$454M
| $1.09M | ﹤0.01% |
70,550
+1,100
| +2% | +$16.9K |
|
1788
SiriusPoint
SPNT
$2.12B
| $1.08M | ﹤0.01% |
146,200
+2,100
| +1% | +$15.6K |
|
|
SVM
1789
Silvercorp Metals
SVM
$1.12B
| $1.08M | ﹤0.01% |
335,500
+13,200
| +4% | +$42.5K |
|
|
TVRD
1790
Tvardi Therapeutics, Inc. Common Stock
TVRD
$323M
| $1.08M | ﹤0.01% |
2,264
+36
| +2% | +$17.1K |
|
|
BIG
1791
DELISTED
Big Lots, Inc.
BIG
| $1.08M | ﹤0.01% |
75,706
+1,200
| +2% | +$17.1K |
|
1792
Invesco Mortgage Capital
IVR
$502M
| $1.07M | ﹤0.01% |
31,470
+4,180
| +15% | +$143K |
|
1793
Enviri
NVRI
$996M
| $1.07M | ﹤0.01% |
153,700
| – | – |
|
|
AEGN
1794
DELISTED
Aegion Corp
AEGN
| $1.07M | ﹤0.01% |
59,700
+900
| +2% | +$16.1K |
|
1795
WillScot Mobile Mini Holdings
WSC
$4.22B
| $1.07M | ﹤0.01% |
105,500
+1,500
| +1% | +$15.2K |
|
|
MODN
1796
DELISTED
MODEL N, INC.
MODN
| $1.07M | ﹤0.01% |
48,000
+1,100
| +2% | +$24.4K |
|
1797
CEVA Inc
CEVA
$586M
| $1.07M | ﹤0.01% |
42,700
+700
| +2% | +$17.5K |
|
1798
Ultra Clean Holdings
UCTT
$1.18B
| $1.07M | ﹤0.01% |
77,200
+1,500
| +2% | +$20.7K |
|
1799
CorVel
CRVL
$4.21B
| $1.06M | ﹤0.01% |
58,500
+600
| +1% | +$10.9K |
|
|
AIMT
1800
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $1.06M | ﹤0.01% |
73,674
+1,800
| +3% | +$25.9K |
|